Securian Asset Management, Inc Bio Rad Laboratories, Inc. Transaction History

Securian Asset Management, Inc

  • $3.43 Billion
  • Q3 2024

A detailed history of Securian Asset Management, Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Securian Asset Management, Inc holds 1,489 shares of BIO stock, worth $521,492. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,489
Previous 1,190 25.13%
Holding current value
$521,492
Previous $325,000 53.23%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$263.97 - $344.64 $78,927 - $103,047
299 Added 25.13%
1,489 $498,000
Q1 2024

Apr 26, 2024
SELL
$304.11 - $351.99 $30,411 - $35,199
-100 Reduced 7.75%
1,190 $411,000
Q4 2023

Feb 08, 2024
SELL
$269.37 - $365.04 $43,368 - $58,771
-161 Reduced 11.1%
1,290 $416,000
Q3 2023

Oct 30, 2023
SELL
$350.25 - $422.63 $154,110 - $185,957
-440 Reduced 23.27%
1,451 $520,000
Q1 2023

Apr 27, 2023
BUY
$418.69 - $503.0 $41,869 - $50,300
100 Added 5.58%
1,891 $905,000
Q4 2022

Feb 02, 2023
SELL
$351.71 - $456.01 $31,653 - $41,040
-90 Reduced 4.78%
1,791 $753,000
Q1 2022

May 03, 2022
SELL
$524.57 - $735.42 $31,474 - $44,125
-60 Reduced 3.09%
1,881 $1.06 Million
Q4 2021

Feb 10, 2022
SELL
$708.84 - $794.68 $19,138 - $21,456
-27 Reduced 1.37%
1,941 $1.47 Million
Q1 2021

May 10, 2021
SELL
$547.01 - $662.35 $54,701 - $66,235
-100 Reduced 4.84%
1,968 $1.12 Million
Q2 2020

Aug 06, 2020
SELL
$334.87 - $493.06 $54,248 - $79,875
-162 Reduced 7.26%
2,068 $934,000
Q4 2019

Feb 04, 2020
SELL
$319.73 - $374.2 $58,190 - $68,104
-182 Reduced 7.55%
2,230 $825,000
Q3 2019

Nov 12, 2019
BUY
$304.55 - $345.24 $5,481 - $6,214
18 Added 0.75%
2,412 $803,000
Q2 2019

Aug 05, 2019
SELL
$286.93 - $312.59 $38,161 - $41,574
-133 Reduced 5.26%
2,394 $748,000
Q1 2018

Apr 30, 2018
BUY
$233.97 - $274.11 $23,397 - $27,411
100 Added 4.12%
2,527 $632,000
Q4 2017

Feb 05, 2018
SELL
$216.94 - $271.3 $21,694 - $27,130
-100 Reduced 3.96%
2,427 $579,000
Q3 2017

Nov 03, 2017
SELL
$212.27 - $242.28 $21,227 - $24,228
-100 Reduced 3.81%
2,527 $562,000
Q2 2017

Aug 14, 2017
BUY
N/A
2,627
2,627 $595,000

Others Institutions Holding BIO

# of Institutions
456
Shares Held
18.2M
Call Options Held
17.6K
Put Options Held
13.3K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.63B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Securian Asset Management, Inc Portfolio

Follow Securian Asset Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email